JPH0261262B2 - - Google Patents
Info
- Publication number
- JPH0261262B2 JPH0261262B2 JP58186620A JP18662083A JPH0261262B2 JP H0261262 B2 JPH0261262 B2 JP H0261262B2 JP 58186620 A JP58186620 A JP 58186620A JP 18662083 A JP18662083 A JP 18662083A JP H0261262 B2 JPH0261262 B2 JP H0261262B2
- Authority
- JP
- Japan
- Prior art keywords
- ser
- polyurethane
- ome
- mdi
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004814 polyurethane Substances 0.000 claims description 54
- 229920002635 polyurethane Polymers 0.000 claims description 37
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 229920001223 polyethylene glycol Polymers 0.000 claims description 22
- 239000012528 membrane Substances 0.000 claims description 17
- 125000004122 cyclic group Chemical group 0.000 claims description 13
- 125000005442 diisocyanate group Chemical group 0.000 claims description 13
- -1 polytetramethylene Polymers 0.000 claims description 11
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims description 8
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims description 5
- 239000000539 dimer Substances 0.000 claims description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 57
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- 238000000034 method Methods 0.000 description 19
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 108010016626 Dipeptides Proteins 0.000 description 17
- 150000002009 diols Chemical class 0.000 description 16
- WMKCPTRURVRKRM-RYUDHWBXSA-N methyl (2s)-3-hydroxy-2-[[(2s)-3-hydroxy-2-(phenylmethoxycarbonylamino)propanoyl]amino]propanoate Chemical compound COC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)OCC1=CC=CC=C1 WMKCPTRURVRKRM-RYUDHWBXSA-N 0.000 description 16
- BJZYYSAMLOBSDY-QMMMGPOBSA-N (2s)-2-butoxybutan-1-ol Chemical compound CCCCO[C@@H](CC)CO BJZYYSAMLOBSDY-QMMMGPOBSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 10
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 10
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 9
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 9
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 9
- 229960001153 serine Drugs 0.000 description 9
- 230000009102 absorption Effects 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 238000000502 dialysis Methods 0.000 description 8
- 238000002329 infrared spectrum Methods 0.000 description 8
- 229920006264 polyurethane film Polymers 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000004202 carbamide Substances 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 230000035699 permeability Effects 0.000 description 7
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 7
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- CINAUOAOVQPWIB-JTQLQIEISA-N methyl (2s)-3-hydroxy-2-(phenylmethoxycarbonylamino)propanoate Chemical compound COC(=O)[C@H](CO)NC(=O)OCC1=CC=CC=C1 CINAUOAOVQPWIB-JTQLQIEISA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004970 Chain extender Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 4
- 150000001371 alpha-amino acids Chemical class 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- NDBQJIBNNUJNHA-DFWYDOINSA-N methyl (2s)-2-amino-3-hydroxypropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CO NDBQJIBNNUJNHA-DFWYDOINSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229940116269 uric acid Drugs 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- ANSUDRATXSJBLY-VKHMYHEASA-N methyl (2s)-2-amino-3-hydroxypropanoate Chemical compound COC(=O)[C@@H](N)CO ANSUDRATXSJBLY-VKHMYHEASA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- GNIDSOFZAKMQAO-VIFPVBQESA-N (2s)-3-hydroxy-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 GNIDSOFZAKMQAO-VIFPVBQESA-N 0.000 description 1
- FKTHNVSLHLHISI-UHFFFAOYSA-N 1,2-bis(isocyanatomethyl)benzene Chemical compound O=C=NCC1=CC=CC=C1CN=C=O FKTHNVSLHLHISI-UHFFFAOYSA-N 0.000 description 1
- MTZUIIAIAKMWLI-UHFFFAOYSA-N 1,2-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC=C1N=C=O MTZUIIAIAKMWLI-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QLOKJRIVRGCVIM-UHFFFAOYSA-N 1-[(4-methylsulfanylphenyl)methyl]piperazine Chemical compound C1=CC(SC)=CC=C1CN1CCNCC1 QLOKJRIVRGCVIM-UHFFFAOYSA-N 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- FZRCKLPSHGTOAU-UHFFFAOYSA-N 6-amino-1,4-dimethylcyclohexa-2,4-diene-1-carbaldehyde Chemical compound CC1=CC(N)C(C)(C=O)C=C1 FZRCKLPSHGTOAU-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical group CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 125000005011 alkyl ether group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- KORSJDCBLAPZEQ-UHFFFAOYSA-N dicyclohexylmethane-4,4'-diisocyanate Chemical compound C1CC(N=C=O)CCC1CC1CCC(N=C=O)CC1 KORSJDCBLAPZEQ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 238000007603 infrared drying Methods 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- 239000000113 methacrylic resin Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
Description
この発明は生体機能性に優れたポリウレタン膜
の製造法に係わるものである。
ポリウレタンはオリゴマージオールとジイソシ
アナートとの重付加反応によつてプレポリマーを
合成した後、鎖延長剤で高分子量化したものであ
り、通常エーテル結合、ウレタン結合、ウレア結
合が含まれている。このウレタン結合、ウレア結
合のN−Hがプロトンドナーとなり、エーテル結
合のエーテル酸素、ウレタン、ウレア結合のカル
ボニル酸素がプロトンアクセプターとなつて、こ
の結合グループの間で分子間水素結合を形成し、
ポリウレタンは球晶構造や抗血栓性に有効なミク
ロ相分離構造をとつている。
α−アミノ酸の線状あるいは環状の2量体には
水素結合能の強いペプチド結合が含まれている。
α−アミノ酸の環状2量体は分子骨格が剛直であ
るため結晶性が良い。これに対しα−アミノ酸の
線状2量体では柔軟な分子骨格を有するため結晶
性は環状2量体の場合より低くなる。従つてα−
アミノ酸の側鎖に水酸基を有するL−セリンの線
状または環状2量体はポリウレタンの鎖延長剤と
して使用できるだけでなく、従来のポリウレタン
には含まれていなかつた水素結合能の高いペプチ
ド結合を含むため新しい形態の相構造の発現が期
待される。また環状2量体と線状2量体の使い分
けによつてポリウレタンの結晶性を変える事がで
き、ポリウレタン膜の膜機能の微妙な調節が可能
となる。
オリゴマージオールはその種類や重合度を変え
る事によつてソフトセグメント部分の性質を調節
できる。オリゴマージオールとしてポリテトラメ
チレングリコールのみを用いた場合、膜の含水率
は小さいが、これに親水性のポリエチレングリコ
ールを共存させると得られたポリウレタン膜の含
水率は高くなり、尿毒関連物質の分離、除去に適
し、透析療法用透析膜としての利用が考えらる。
このような背景下にあつて、本発明者等は尿毒
関連物質透過性に優れ、しかも生体適合性を有す
る膜材料を提供することを目的として鋭意研究を
重ね、本発明を完成するに到つた。即ち本発明の
要旨は水酸基をもつたα−アミノ酸の線状2量体
又は環状2量体とポリテトラメチレングリコール
及びポリエチレングリコールを共存させてジイソ
シアナートと重付加反応させ、得られたポリウレ
タンを成膜することを特徴とする生体機能性膜の
製造法に存するものである。
以下、本発明を詳細に説明する。
() 線状ジペプチドを一成分とするポリウレ
タンの合成:
このものは側鎖に水酸基を有するα−アミノ酸
を縮合させてジペプチドジオールを合成し、これ
を鎖延長剤としてポリテトラメチレングリコール
及びポリエチレングリコールを共存させ、ジイソ
シアナートとの重付加反応を行なわせることによ
つて得られる。
(A) 線状ジペプチドジオールの合成:
側鎖に水酸基を有するα−アミノ酸としてL−
セリン(以下L−セリンをH−Ser−OHと略記
する)を使用する例について述べる。H−Ser−
OHの線状ジペプチドは、アミノ末端をカルボベ
ンジルオキシ化(以下カルボベンジルオキシ基を
Zと略記する)したZ−Ser−OHのカルボキシ
ル末端を活性化し、これを、別にH−Ser−OH
のカルボキシル基をメチルエステル化したH−
Ser−OMeと縮合させることにより、両末端基を
保護したセリンの線状ジペプチド、すなわちZ−
Ser−Ser−OMeが得られる。
これを具体的に例示すると、20gのH−Ser−
OHをメタノール中に懸濁させ、0℃に保つて塩
化水素ガスを約6時間通気する。次いでメタノー
ルを留去し、得られる固体をメタノールから再結
晶することにより、H−Ser−OMe・HCl 17.7g
を得た(収率59%)。このものの融点は162〜165
℃であり、薄層クロマトグラフイ(以下TLCと
いう)と赤外(以下IRという)スペクトルによ
り純粋なH−Ser−OMe・HClの得られたことが
確認された。
8gのH−Ser−OMe・HClを炭酸水素ナトリ
ウムの飽和水溶液に加え、約20℃に保ち、撹拌し
ながら10gのZ−Cl(H−Ser−OMe・HClの1.1
倍当量となる)を滴下し、4時間反応させる。分
離した油層を酢酸エチルで抽出し、抽出液を5%
塩酸、次いで水で洗浄し、無水硫酸ナトリウム上
で乾燥したのち、酢酸エチルを留去する。得られ
た固体をペンタンとエーテルとの混合溶媒から再
結晶してZ−Ser−OMe10.4gを得た(収率80
%)。このものの融点は27〜32℃であり、TLC、
IRスペクトル、高速液体クロマトグラフイ(以
下HPLCという)により、純粋なZ−Ser−OMe
の得られたことが確認された。
9.7gのZ−Ser−OMeをメタノールに溶かし、
抱水ヒドラジン5.75g(Z−Ser−OMeの3倍当
量)を加え、約20℃で24時間反応させた。次にエ
ーテルを加え、さらに0℃で5〜6時間反応させ
る。沈澱を取し、メタノールとエーテルの混合
溶媒から再結晶してZ−Ser−NHNH2の針状結
晶7.8gを得た(収率80%)。このものの融点は
180〜181℃であり、TLCおよびIRスペクトルに
より純粋なZ−Ser−NHNH2の得られたことが
確認された。
以上のようにして得られたZ−Ser−
NHNH27.59gをジメチルホルムアミドに溶か
し、−5℃で撹拌しながら3.51gの亜硝酸イソア
ミル(Z−Ser−NHNH2と等モル量)を加える。
溶媒中にはZ−Ser−N3が生成したと考えられる
が、このものを単離することなく、以下の反応に
供した。すなわち、この反応液に、上に合成した
H−Ser−OMe・HCl 4.67g(Z−Ser−
NHNH2と等モル量)のジメチルホルムアミド溶
液(少量のトリエチルアミンを含む)を加え、0
℃で2日間反応させた。揮発分を留去し、残渣を
酢酸エチルで抽出し、この抽出液を4%炭酸水素
ナトリウム水溶液、3%塩酸、そして水で洗浄
し、無水硫酸ナトリウム上で乾燥したのち、酢酸
エチルを留去した。得られた固体を酢酸エチルと
石油エーテルの混合物で再結晶し、Z−Ser−
Ser−OMeの針状結晶3.3gを得た(収率32.3%)。
このものの融点は142〜144℃であり、TLC、IR
スペクトルおよび元素分析により純粋なZ−Ser
−Ser−OMeの得られたことが確認された。メタ
ノール溶液の〔α〕24/Dは−3.1゜であつた。
上記の反応を式で示すと次の通りである。
H−Ser−OHMeOH/HCl
―――――――――→
H−Ser
−OMe・HCl2Cl
―――→
Z−Ser
−OMe・HClNH2NH2
―――――――→
Z−Ser
−NHNH2C5H11NO2
――――――――→
Z−Ser−N3
H−Ser−OMe・HCl
――――――――――――→
Z−Ser−Sef−OMe
この方法によればセリンの側鎖基は保護しなく
とも修飾や妨害なしに所定の反応が進行し、極め
て効率よくZ−Ser−Ser−OMeを得ることがで
きる。Z−Ser−Ser−OMeは下記の化学構造を
有し、ジオール成分としてジイソシアナートとの
重付加反応によるポリウレタンの合成が可能であ
る。
(B) 線状ジペプチドジオールを含むポリウレタン
の合成:
上記(A)記載のようにして得られた線状ジペプチ
ドジオールに種々の重合度のポリテトラメチレン
グリコール(以下、ポリテトラメチレングリコー
ルをPTMGと略記する)及びポリエチレングリ
コール(以下、ポリエチレングリコールをPEG
と略記する)を共存させ、これをジイソシアナー
トと重付加反応を行なわせる。PTMGとPEGと
の使用割合は通常、モル比で約1対1の範囲から
選ばれるのがよい。
上記重付加反応において、ジイソシアナートと
して、メチレンビス(4−ジイソシアナートベン
ゼン)(以下、これをMDIと略記する)を使用し
た場合の例を説明する。
例 1
分子量1336のPTMG(以下、PTMG1336と略
記する。その後の記載においてもPTMGの後に
付した数値はそのものの分子量を表わす。)、分子
量1540のPEG(以下、PEG1540と略記する。その
後の記載においてもPEGの後に付した数値はそ
のものの分子量を表わす。)、MDI及び上記(A)に
よつて得られたZ−Ser−Ser−OMeを成分とす
るポリウレタン〔以下、このポリウレタンをPU
(PTMG1336/PEG1540、MDI、Z−Ser−Ser
−OMe)と略記する〕の製造:
0.39gのPTMG1336と0.45gのPEG1540との等
量混合物を8mlのジメチルホルムアミドに溶か
し、0.29gのMDI(PTMG,PEGの2倍モルに相
当する)を2mlのホルムアミドに溶かした溶液と
混合し、窒素置換した後60℃で1時間反応させ
た。その後、0.20gのZ−Ser−Ser−OMe
(PTMG,PEGと等モル)を2mlのジメチルホル
ムアミドに溶かした溶液を加え、50℃で24時間反
応させた。その後、溶媒のジメチルホルムアミド
を留去し、粘い溶液を水中に注ぐと粘性のある少
し褐色に着色したポリマーが得られた。これを蒸
留水で2回洗浄した後、光を遮断して五酸化リン
上で24時間乾燥させた。このポリウレタンをジメ
チルホルムアミドに溶かし、30℃における粘度を
測定したところ、〔η〕=0.35であつた。この条件
でポリメタクリル酸メチルに対して報告されてい
る〔η〕と分子量の関係式を適用して計算した分
子量は約31万であつた。
分子量1100のPTMG(以下PTGM1100と略記
する)と分子量1000のPEG(以下、PEG100と略
記する)との組合せ及び分子量2117のPTMG(以
下PTMG2117と略記する)と分子量2000のPEG
(以下、PEG2000と略記する)との組合せを用
い、同様の操作によりポリウレタンを合成した。
得られたPU(PTMG1100/PEG1000、MDI、Z
−Ser−Ser−OMe)は褐色で、〔η〕=0.31、換
算分子量は約23万であつた。またPU
(PTMG2117/PEG2000、MDI、Z−Ser−Ser
−OMe)は淡黄色で、〔η〕=0.36、換算分子量
は約34万であつた。
これらのポリウレタンの溶解性は、ヘキサメチ
ルホスホアミド、ジメチルスルホキシド、ジメチ
ルホルムアミドに可溶、水、アセトニトリル、メ
タノール、クロロホルム、ベンゼン、ジオキサン
に不溶であつた。
PU(PTMG2117/PEG2000、MDI、Z−Ser
−Ser−OMe)のぬりつけ法によるIRスペクトル
を図1に示す。このIRスペクトルにおいて1720
cm-1(図中、Aで示す箇所)に観測される吸収は
ウレタン結合とエステル基に基づくものである。
1650cm-1(図中、Bで示す箇所)に観測される吸
収はZ−Ser−Ser−OMe成分のアミド基のアミ
ドに基づくものである。1540cm-1(図中、Cで
示す箇所)に観測される吸収はZ−Ser−Ser−
OMe成分のアミド基のアミドとフエニル基
This invention relates to a method for producing a polyurethane membrane with excellent biological functionality. Polyurethane is a prepolymer synthesized by a polyaddition reaction between an oligomer diol and a diisocyanate, and then increased in molecular weight with a chain extender, and usually contains ether bonds, urethane bonds, and urea bonds. The N-H of this urethane bond and urea bond becomes a proton donor, and the ether oxygen of the ether bond, and the carbonyl oxygen of the urethane and urea bonds become proton acceptors, forming intermolecular hydrogen bonds between these bond groups,
Polyurethane has a spherulite structure and a microphase separation structure that is effective for antithrombotic properties. Linear or cyclic dimers of α-amino acids contain peptide bonds with strong hydrogen bonding ability.
The cyclic dimer of α-amino acid has a rigid molecular skeleton and therefore has good crystallinity. On the other hand, since linear dimers of α-amino acids have flexible molecular skeletons, their crystallinity is lower than that of cyclic dimers. Therefore α−
The linear or cyclic dimer of L-serine, which has a hydroxyl group in the amino acid side chain, can not only be used as a chain extender for polyurethane, but also contains peptide bonds with high hydrogen bonding capacity that were not contained in conventional polyurethane. Therefore, the development of a new form of phase structure is expected. Furthermore, by selectively using a cyclic dimer and a linear dimer, the crystallinity of polyurethane can be changed, making it possible to finely control the film function of a polyurethane film. The properties of the soft segment portion of the oligomer diol can be adjusted by changing its type and degree of polymerization. When only polytetramethylene glycol is used as the oligomer diol, the moisture content of the membrane is small, but when hydrophilic polyethylene glycol is used together with this, the moisture content of the resulting polyurethane membrane increases, making it easier to separate urinary toxin-related substances. It is suitable for removal and can be used as a dialysis membrane for dialysis therapy. Against this background, the present inventors have conducted extensive research with the aim of providing a membrane material that has excellent permeability to urinary toxin-related substances and is biocompatible, and have completed the present invention. . That is, the gist of the present invention is to coexist polytetramethylene glycol and polyethylene glycol with a linear dimer or cyclic dimer of an α-amino acid having a hydroxyl group, to cause a polyaddition reaction with a diisocyanate, and to process the resulting polyurethane. The present invention resides in a method for producing a biofunctional membrane, which is characterized by forming a membrane. The present invention will be explained in detail below. () Synthesis of polyurethane containing linear dipeptide as one component: This product synthesizes dipeptide diol by condensing an α-amino acid having a hydroxyl group in the side chain, and using this as a chain extender, polytetramethylene glycol and polyethylene glycol are added. It can be obtained by coexisting with diisocyanate and performing a polyaddition reaction with diisocyanate. (A) Synthesis of linear dipeptide diol: L-amino acid having a hydroxyl group in the side chain
An example using serine (hereinafter L-serine will be abbreviated as H-Ser-OH) will be described. H-Ser-
The linear dipeptide of OH activates the carboxyl terminal of Z-Ser-OH whose amino terminal is carbobenzyloxylated (hereinafter the carbobenzyloxy group is abbreviated as Z), and this is separately converted into H-Ser-OH.
The carboxyl group of H- is methyl esterified.
By condensation with Ser-OMe, a linear dipeptide of serine with both terminal groups protected, i.e., Z-
Ser−Ser−OMe is obtained. To specifically illustrate this, 20g of H-Ser-
The OH is suspended in methanol, kept at 0° C., and hydrogen chloride gas is bubbled through for about 6 hours. Next, methanol was distilled off, and the resulting solid was recrystallized from methanol to yield 17.7 g of H-Ser-OMe.HCl.
was obtained (yield 59%). The melting point of this thing is 162-165
℃, and it was confirmed by thin layer chromatography (hereinafter referred to as TLC) and infrared (hereinafter referred to as IR) spectrum that pure H-Ser-OMe.HCl was obtained. Add 8 g of H-Ser-OMe.HCl to a saturated aqueous solution of sodium bicarbonate, keep at about 20°C, and add 10 g of Z-Cl (1.1 of H-Ser-OMe.HCl) while stirring.
(double equivalent amount) was added dropwise and allowed to react for 4 hours. The separated oil layer was extracted with ethyl acetate, and the extract was diluted with 5%
After washing with hydrochloric acid and then water and drying over anhydrous sodium sulfate, ethyl acetate is distilled off. The obtained solid was recrystallized from a mixed solvent of pentane and ether to obtain 10.4 g of Z-Ser-OMe (yield: 80
%). The melting point of this product is 27-32℃, TLC,
Pure Z-Ser-OMe was determined by IR spectrum and high-performance liquid chromatography (hereinafter referred to as HPLC).
It was confirmed that the results were obtained. Dissolve 9.7g of Z-Ser-OMe in methanol,
5.75 g of hydrazine hydrate (3 times the equivalent of Z-Ser-OMe) was added, and the mixture was reacted at about 20°C for 24 hours. Next, ether is added and the mixture is further reacted at 0° C. for 5 to 6 hours. The precipitate was collected and recrystallized from a mixed solvent of methanol and ether to obtain 7.8 g of needle-like crystals of Z-Ser-NHNH 2 (yield: 80%). The melting point of this thing is
The temperature was 180-181°C, and it was confirmed by TLC and IR spectra that pure Z-Ser-NHNH 2 was obtained. Z−Ser− obtained as above
7.59 g of NHNH 2 is dissolved in dimethylformamide and 3.51 g of isoamyl nitrite (equimolar amount of Z-Ser-NHNH 2 ) is added while stirring at -5°C.
Although it is thought that Z-Ser-N 3 was generated in the solvent, this product was subjected to the following reaction without being isolated. That is, 4.67 g of H-Ser-OMe・HCl (Z-Ser-OMe・HCl synthesized above) was added to this reaction solution.
A dimethylformamide solution (containing a small amount of triethylamine) of 0.0
The reaction was carried out at ℃ for 2 days. The volatile components were distilled off, and the residue was extracted with ethyl acetate. This extract was washed with a 4% aqueous sodium bicarbonate solution, 3% hydrochloric acid, and water, dried over anhydrous sodium sulfate, and then the ethyl acetate was distilled off. did. The obtained solid was recrystallized from a mixture of ethyl acetate and petroleum ether to give Z-Ser-
3.3 g of needle-like crystals of Ser-OMe were obtained (yield 32.3%).
The melting point of this product is 142-144℃, TLC, IR
Pure Z-Ser by spectroscopy and elemental analysis
It was confirmed that -Ser-OMe was obtained. [α] 24/D of the methanol solution was −3.1°. The above reaction is expressed as follows. H−Ser−OHMeOH/HCl ――――――――→ H−Ser −OMe・HCl2Cl ――――→ Z−Ser −OMe・HClNH 2 NH 2 ――――――――→ Z−Ser − NHNH 2 C 5 H 11 NO 2 ――――――――→ Z−Ser−N 3 H−Ser−OMe・HCl ――――――――――→ Z−Ser−Sef−OMe According to this method, the desired reaction proceeds without modification or interference even if the side chain group of serine is not protected, and Z-Ser-Ser-OMe can be obtained extremely efficiently. Z-Ser-Ser-OMe has the following chemical structure, and polyurethane can be synthesized by polyaddition reaction with diisocyanate as a diol component. (B) Synthesis of polyurethane containing linear dipeptide diol: Polytetramethylene glycol with various degrees of polymerization (hereinafter, polytetramethylene glycol is abbreviated as PTMG) is added to the linear dipeptide diol obtained as described in (A) above. ) and polyethylene glycol (hereinafter referred to as polyethylene glycol) and polyethylene glycol (hereinafter referred to as PEG)
(hereinafter abbreviated as )) are allowed to coexist, and this is subjected to a polyaddition reaction with diisocyanate. The ratio of PTMG to PEG to be used is usually selected from a molar ratio of approximately 1:1. An example will be described in which methylene bis(4-diisocyanatobenzene) (hereinafter abbreviated as MDI) is used as the diisocyanate in the above polyaddition reaction. Example 1 PTMG with a molecular weight of 1336 (hereinafter abbreviated as PTMG1336. Also in the subsequent descriptions, the number after PTMG represents the molecular weight of itself), PEG with a molecular weight of 1540 (hereinafter abbreviated as PEG1540. In the subsequent descriptions) The number added after PEG indicates its molecular weight), MDI and polyurethane containing Z-Ser-Ser-OMe obtained by (A) above [hereinafter, this polyurethane will be referred to as PU
(PTMG1336/PEG1540, MDI, Z-Ser-Ser
-OMe)]: Dissolve an equal mixture of 0.39 g of PTMG1336 and 0.45 g of PEG1540 in 8 ml of dimethylformamide, and add 0.29 g of MDI (corresponding to twice the mole of PTMG, PEG) to 2 ml. The mixture was mixed with a solution dissolved in formamide, and the atmosphere was replaced with nitrogen, followed by reaction at 60°C for 1 hour. Then 0.20 g of Z−Ser−Ser−OMe
A solution prepared by dissolving PTMG (equal moles of PEG) in 2 ml of dimethylformamide was added, and the mixture was reacted at 50°C for 24 hours. Thereafter, the solvent dimethylformamide was distilled off, and the viscous solution was poured into water, yielding a viscous slightly brown colored polymer. This was washed twice with distilled water and then dried over phosphorus pentoxide for 24 hours in the absence of light. When this polyurethane was dissolved in dimethylformamide and its viscosity at 30°C was measured, it was found that [η]=0.35. Under these conditions, the molecular weight calculated by applying the relationship between [η] and molecular weight reported for polymethyl methacrylate was approximately 310,000. A combination of PTMG with a molecular weight of 1100 (hereinafter abbreviated as PTGM1100) and PEG with a molecular weight of 1000 (hereinafter abbreviated as PEG100), and PTMG with a molecular weight of 2117 (hereinafter abbreviated as PTMG2117) and PEG with a molecular weight of 2000
(hereinafter abbreviated as PEG2000), polyurethane was synthesized in the same manner.
Obtained PU (PTMG1100/PEG1000, MDI, Z
-Ser-Ser-OMe) was brown in color, [η] = 0.31, and the equivalent molecular weight was approximately 230,000. Also PU
(PTMG2117/PEG2000, MDI, Z-Ser-Ser
-OMe) was pale yellow, [η] = 0.36, and the equivalent molecular weight was approximately 340,000. The solubility of these polyurethanes was that they were soluble in hexamethylphosphoamide, dimethylsulfoxide, and dimethylformamide, and insoluble in water, acetonitrile, methanol, chloroform, benzene, and dioxane. PU (PTMG2117/PEG2000, MDI, Z-Ser
-Ser-OMe) obtained by the staining method is shown in Figure 1. 1720 in this IR spectrum
The absorption observed at cm -1 (location indicated by A in the figure) is based on urethane bonds and ester groups.
The absorption observed at 1650 cm -1 (location indicated by B in the figure) is based on the amide of the amide group of the Z-Ser-Ser-OMe component. The absorption observed at 1540cm -1 (point C in the figure) is Z-Ser-Ser-
Amide and phenyl group of amide group of OMe component
【式】に基づく吸収が観測され、MDIが
ポリウレタン鎖中に存在することが確認された。
また1100cm-1(図中、Dで示す箇所)に観測され
る吸収はアルキルエーテル基−CH2−O−CH2−
に基づくものである。
これらの事実に基づき、上記の反応は次のよう
になり、その得られたポリウレタンは下記の構造
をとると考えられる。
() 線状ジペプチドを一成分とするポリウレ
タンの合成:
このものは側鎖に水酸基を有するα−アミノ酸
を環化縮合させて環状ジペプチドジオールを合成
し、これを鎖延長剤としてポリテトラメチレング
リコール及びポリエチレングリコールを共存さ
せ、ジイソシアナートとの重付加反応を行なうこ
とによつて得られる。
(A) 環状ジペプチドジオールの合成:
側鎖に水酸基を有するα−アミノ酸としてL−
セリンを使用する例について述べる。
上記()の(A)の方法で合成したZ−Ser−
Ser−OMe1.5gを40mlのメタノール(HClを飽和
させておく)に溶かし、0.3gのPd黒を加え、水
素を約5時間通気する。溶液を過し、メタノー
ルを留去して得られる残渣を数回n−ヘキサンで
洗浄し、Z−Ser−Ser−OMe・HCl 1.0gを得
た(収率93.6%)。TLCとIRスペクトルにより純
粋なZ−Ser−Ser−OMe・HClの得らたことが
確認された。
このようにして得られたH−Ser−Ser−
OMe・HCl 1.0gを41mlのメタノール(NH3を
飽和させておく)に溶かし(H−Ser−Ser−
OMeの濃度が0.1Mとなる)、室温で24時間反応
させた。揮発分を留去し、残渣をn−ヘキサンで
洗うと、L−セリンが環化縮合したジペプチドジ
オール〔以下これをC−(Ser)2と略記する〕の針
状結晶が0.55g得られた(収率76.7%)。このも
のの融点は245〜248℃であり、元素分析及びIR
スペクトルにより純粋なC−(Ser)2の得られたこ
とが確認された。
上記の反応を式で示すと次の通りである。
Z−Ser−Ser−OMeH2/Pd
――――――――――→
HCl/MeOHH
−Ser−Ser−OMe・HClNH3/MeOH
―――――――――→
C(Ser)2
この方法によれば、セリンの側鎖水酸基は保護
しなくとも修飾が妨害なしに所定の反応が進行
し、極めて効率よくC−(Ser)2を得ることができ
る。C−(Ser)2は下記の化学構造を有し、ジオー
ル成分としてジイソシアナートとの重付加反応に
よりポリウレタンを合成することができる。
(B) 環状ジペプチドジオールを含むポリウレタン
の合成:
上記(A)記載のようにして得られた環状ジペプチ
ドジオールを種々の重合度のPTMG及びPEGと
混合し、ジイソシアナートでもつて重付加反応を
行なわせる。PTMGとPEGとの混合割合は、一
般的にいつて上記()の場合におけると同様で
よい。ジイソシアナートとしてMDIを使用した
場合の例を次に示す。
例 2
PTMG1100/PEG1000、MDI及びC−(Ser)2
を成分とするポリウレタン〔以下、このポリウレ
タンをPU〔PTMG1100/PEG1000、MDI、C−
(Ser)2〕と略記する〕の製造:
0.32gのPTMG1100と0.29gのPEG1000との等
量混合物を8mlのジメチルホルムアミドに溶か
し、0.29gのMDI(PTMG,PEGの2倍モルに相
当する)を2mlのホルムアミドに溶かした溶液と
混合し、窒素置換した後60℃で1時間反応させ
た。その後、0.1gのC−(Ser)2(PTMG,PEG
と等モル)を10mlのジメチルホルムアミドに溶か
した溶液を加え、50℃で24時間反応させた。反応
終了後、溶媒のジメチルホルムアミドを留去して
濃縮し、残渣を水に注いでポリウレタンを沈澱さ
せる。これを五酸化リン上で減圧乾燥すると淡褐
色のポリウレタンが得られた。このものは含水率
が高く、23%の含水率を示した。アルキレンジオ
ールとしてPTMG1336/PEG1540、または
PTMG2117/PEG2000の組合せを用い、同様の
操作によりポリウレタンを合成した。含水率は、
PU〔PTMG1336/PEG1540,MDI,C−(Ser)2〕
では42%、PU〔PTMG2117/PEG2000,MDI,
C−(Ser)2〕では41%であつた。また、これらの
ポリウレタンをジメチルホルムアミドに溶かし、
30℃における粘度を測定して〔η〕を求め、この
条件でポリメタクリル酸メチルに対して報告され
ている〔η〕と分子量の関係式を適用して分子量
を求めたところ、PU〔PTMG1110/PEG1000,
MDI,C−(Ser)2〕では〔η〕=0.29、分子量20
万、PU〔PTMG1336/PEG1540,MDI,C−
(Ser)2〕では〔η〕=0.32、分子量25万、PU
〔PTMG2117/PEG2000,MDI,C−(Ser)2〕で
は〔η〕=0.34、分子量29万であつた。
PU〔PTMG1100/PEG1000,MDI,C−
(Ser)2〕のKBr法によるIRスペクトルを図2に
示す。このIRスペクトルにおいて、1520cm-1
(図中、D)と1660cm-1(図中、B)に観測され
る吸収はC−(Ser)2成分のアミド基に基づくもの
である。1700cm-1(図中、A)に観測される吸収
はポリウレタンの生成に伴つて生じるウレタン結
合に基づくものである。1590cm-1(図中、C)に
観測される吸収はMDIのフエニル基に基づくも
のである。これらの事実に基づき、上記の反応に
おいて得られたポリウレタンは下記の構造をとる
と考えられる。
本発明によるセグメント化ポリウレタンの製造
は上に述べた場合に限られるものでなく、その他
の場合をも含むものである。例えば、ポリウレタ
ンを製造する場合に使用するジペプチドジオール
の成分の水酸基をもつたアミノ酸としては上に挙
げたセリンだけでなく、トレオニンやチロシンを
使用することができる。
これらのα−アミノ酸にはD体とL体が存在す
るが、いずれを使用してもかまわない。また両方
の混合物、ラセミ体の使用も可能である。2種以
上の異なるα−アミノ酸を混合して使用すること
もできる。これらのすべての場合に、線状ジペプ
チドと環状ジペプチドの両方を合成することがで
き、ポリウレタンの原料とすることができる。
線状ジペプチドの場合にはアミノ基とカルボキ
シル基を保護しておく必要がある。アミノ基の保
護基としてはカルボベンジルオキシ基のほかに、
t−ブチロキシカルボニル基やホルミル基を用い
ることができる。またカルボキシル基の保護基と
してはメチルエステル以外にベンジルエステルや
アミドを用いることができる。
本発明方法に従つてPTMGとPEGを混合使用
するときはPTMG単独使用の場合よりも得られ
たポリウレタンの含水率は高くなり、透析膜とし
ての利用価値が高くなる。
ポリウレタンを製造する場合に使用し得るジイ
ソシアナートとしては、上記MDIのほかに、ヘ
キサメチレンジイソシアナート、トルエンジイソ
シアナート、フエニレンジイソシアナート、キシ
リレンジイソシアナートなどの芳香族ジイソシア
ナート、またメチレンビス(4−イソシアナート
シクロヘキサン)、1−カルボメトキシ−1,6
−ジイソシアナートヘキサンなど脂肪族ジイソシ
アナートを挙げることができる。
() 線状または還状ジペプチドジオールを含
むポリウレタン膜の造膜方法:
上記()及び()で説明したようにして得
られたポリウレタンから膜を得るには従来知られ
ている成膜方法に従つて行なうことができる。以
下にその方法を例示する。
例 3
赤外ランプ照射下におけるポリウレタンの造膜
方法:
0.05gのポリウレタンを2mlのジメチルホルム
アミドに溶かし、一昼夜、撹拌して均質溶液とす
る。これを清浄な水平ガラス板上に流延し、ガラ
ス板上方30cmの位置に250Wの赤外線乾燥用ラン
プを1台設置し、防塵用の透明ケースを被せ、蒸
発してくるジメチルホルムアミドを除去するため
の空気を透明ケース内に送り込みながら、ランプ
を5時間、点燈した。得られたポリウレタン膜は
蒸留水中に浸漬すると容易にガラス板からはがれ
てくる。これを五酸化リン上で2日間乾燥させ
た。得られたポリウレタン膜は透明な均質膜で、
膜厚は約20μmであつた。この膜のATR−IRスペ
クトルを測定したが、膜の両面に差はなかつた。
また、この膜の断面構造を調べるために液体窒素
中(−195℃)で膜を破断し、走査型電子顕微鏡
で調べた。その結果、膜の造膜時の空気側表面に
は多数の微細孔が観察されたが、これは赤外ラン
プ照射によるジメチルホルムアミドの急激な蒸散
によつて生じたものと考えられる。
例 4
室温、大気圧下におけるポリウレタンの造膜方
法:
0.05gのポリウレタンを2mlのジメチルホルム
アミドに溶かし、一昼夜、撹拌して均質溶液とす
る。これを清浄な水平ガラス板上に流延し、約25
℃の室温、大気圧下に2日間静置して、徐々にジ
メチルホルムアミドを飛散させた後、3日間真空
乾燥した。得られたポリウレタン膜は蒸留水中に
浸漬すると容易にガラス板から、はがれた。これ
を五酸化リン上でさらに2日間真空乾燥した。得
られた膜は、赤外ランプ照射によつて得られた膜
と同様に透明な均質膜で、膜厚は約20μmであつ
た。この膜のATR−IRスペクトルを測定したが
膜の両面に差はなかつた。
またこの膜の断面構造を調べるために液体窒素
で膜を破断し、走査型電子顕微鏡で調べたとこ
ろ、赤外ランプ照射によつて得られた膜の破断面
にみられるような微細孔はみられなかつた。
造膜方法としては上に例示した以外の方法をと
ることができる。温度は溶媒としてジメチルホル
ムアミドを用いる場合、室温乃至100℃程度の範
囲が適当である。圧力は1気圧乃至0mmHgの範
囲で調節できる。造膜溶媒としてはジメチルホル
ムアミドの他に、ヘキサメチルホスホアミド、ジ
メチルスルホキシド等が使用できる。
次に本発明方法によつて得られるポリウレタン
膜の生体機能性を説明する。
() 尿毒関連物質透過性試験:
本発明方法によつて得られるようなアミノ酸成
分を含む膜では、溶質との選択的相互作用が期待
できるので、生体からの排泄物であるNaCl、ク
レアチニン、尿素、尿酸の溶質を用いて透過性を
測定した。
この試験において用いた試料は次の通りであ
る。
試料(1) PU(PTMG1100/PEG1000,MDI,Z
−Ser−Ser−OMe)
試料(2) PU(PTMG1336/PEG1540,MDI,Z
−Ser−Ser−OMe)
試料(3) PU(PTMG2117/PEG2000,MDI,Z
−Ser−Ser−OMe)
試料(4) PU〔PTMG1100/PEG1000,MDI,C
−(Ser)2〕
試料(5) PU〔PTMG1336/PEG1540,MDI,C
−(Ser)2〕
試料(6) PU〔PTMG2117/PEG2000,MDI,C
−(Ser)2〕
試料(7) 酢酸セルロース
上記の試料(1)〜(7)は、これをジメチルホルムア
ミド溶液とし、赤外ランプ照射法で成膜した。試
料(7)の酢酸セルロースは従来人工腎臓の透析膜素
材として利用されているものであり、比較のため
挙げた。
試験は次のようにして行なつた。試料膜を
0.785cm2の円形の穴のあいた2枚のシリコンゴム
で挾み、両側からメタアクリル樹脂製の透析セル
2個で固定化する。(シリコンゴム、試料膜の密
着性を良くするために、穴以外の部分にシリコン
グリースを用いた。)透析セルの一方に濃度既知
の溶液、他方に蒸留水をそれぞれ100ml入れ、ス
ターラーで撹拌して透過してくる溶質濃度の経時
変化を調べた。また、この試験においては透析セ
ルを25℃の恒温槽中に設置した。透過してくる溶
質濃度の経時変化は、時間毎に蒸留水側の溶液1
mlを採取して濃度決定した。そして理論透過式に
基づきlnC″/C″−2Ctと時間tをプロツトする事によ
り、その傾きから、それぞれの膜に対する透過係
数Pを求めた。
lnC″/C″−2Ct=2PA/δVt
P:透過係数(cm2/min)
A:透過膜面積(cm2)
δ:膜厚(cm)
V:透過セルの容積(cm3)
C″:供給液側の初濃度(mole/cm3)
Ct:t時間後に透過してきた溶質濃度
(mole/cm3)
膜厚は簡易膜厚計を用いて測定した。
各溶質の濃度測定について示すと次のようにな
る。
NaClについては、Mohr法によるCl-の適定で、
クロム酸カリウムを指示薬として定量した。
0.01Nの硝酸銀溶液を滴下していくと最初AgCl
の白沈が生じ、終点を過ぎるとAg2CrO4の赤沈
を生じる。
尿素においては、パラジメチルアミノベンズア
ルデヒドを用い、下記に示したようなシツフ塩基
に誘導して定量した。試料1mlにPDAB・H+溶
液を0.5ml添加し、10分間放置後UVで440nmの吸
光度を測定した。一方濃度既知の尿素標準溶液を
用いて検量線を作成した。この検量線を最小自乗
法によつて求めた。従つて、吸光度から尿素の濃
度を求めることができる。またPDAB・H+溶液
はPDAB5gを特級エタノールに溶解させ、100
mlとし約50mlをメスフラスコ(100ml)に取り、
濃硫酸5mlを静かに加え、PDAB溶液を加えて
100mlとしてPDAB・H+溶液を調製した。
クレアチニン、尿酸はそれぞれの検量線を作成
し、その傾きにより最大吸光係数〓maxを求めた。
そしてこの〓maxを用いて試料の溶質濃度を定量
した。次に尿酸においては水に難溶性なために、
PH9.18のホウ酸緩衝液を用いた。測定結果を次表
に示す。Absorption based on the formula was observed, and it was confirmed that MDI was present in the polyurethane chain.
In addition, the absorption observed at 1100 cm -1 (location indicated by D in the figure) is due to the alkyl ether group -CH 2 -O-CH 2 -
It is based on Based on these facts, the above reaction is as follows, and the resulting polyurethane is considered to have the following structure. () Synthesis of polyurethane containing a linear dipeptide as one component: This product synthesizes a cyclic dipeptide diol by cyclocondensation of an α-amino acid having a hydroxyl group in its side chain, and uses this as a chain extender with polytetramethylene glycol and It can be obtained by carrying out a polyaddition reaction with diisocyanate in the presence of polyethylene glycol. (A) Synthesis of cyclic dipeptide diol: L-amino acid having a hydroxyl group in the side chain
An example using serine will be described. Z-Ser- synthesized by method (A) in () above
Dissolve 1.5 g of Ser-OMe in 40 ml of methanol (saturated with HCl), add 0.3 g of Pd black, and bubble in hydrogen for about 5 hours. The solution was filtered and methanol was distilled off, and the resulting residue was washed several times with n-hexane to obtain 1.0 g of Z-Ser-Ser-OMe.HCl (yield 93.6%). TLC and IR spectra confirmed that pure Z-Ser-Ser-OMe.HCl was obtained. H-Ser-Ser- thus obtained
Dissolve 1.0 g of OMe・HCl in 41 ml of methanol (saturated with NH3 ) (H-Ser-Ser-
(The concentration of OMe was 0.1M) and the reaction was carried out at room temperature for 24 hours. The volatile components were distilled off, and the residue was washed with n-hexane to obtain 0.55 g of needle-shaped crystals of dipeptide diol (hereinafter abbreviated as C-(Ser) 2 ) in which L-serine was cyclized and condensed. (Yield 76.7%). The melting point of this product is 245-248℃, and elemental analysis and IR
The spectrum confirmed that pure C-(Ser) 2 was obtained. The above reaction is expressed as follows. Z−Ser−Ser−OMeH 2 /Pd ――――――――――→ HCl/MeOHH −Ser−Ser−OMe・HClNH 3 /MeOH ――――――――――→ C(Ser) 2 According to this method, even if the side chain hydroxyl group of serine is not protected, the specified reaction proceeds without interference with the modification, and C-(Ser) 2 can be obtained extremely efficiently. C-(Ser) 2 has the following chemical structure, and polyurethane can be synthesized by polyaddition reaction with diisocyanate as a diol component. (B) Synthesis of polyurethane containing cyclic dipeptide diol: The cyclic dipeptide diol obtained as described in (A) above is mixed with PTMG and PEG of various degrees of polymerization, and polyaddition reaction is performed with diisocyanate. let The mixing ratio of PTMG and PEG may generally be the same as in the case () above. An example of using MDI as the diisocyanate is shown below. Example 2 PTMG1100/PEG1000, MDI and C-(Ser) 2
[Hereinafter, this polyurethane will be referred to as PU [PTMG1100/PEG1000, MDI, C-
(Ser) 2 ] Production: Dissolve an equal mixture of 0.32 g of PTMG1100 and 0.29 g of PEG1000 in 8 ml of dimethylformamide, and add 0.29 g of MDI (corresponding to twice the mole of PTMG, PEG). was mixed with a solution dissolved in 2 ml of formamide, the atmosphere was replaced with nitrogen, and the mixture was reacted at 60°C for 1 hour. Then, 0.1 g of C-(Ser) 2 (PTMG, PEG
A solution of 10 ml of dimethylformamide was added, and the mixture was reacted at 50°C for 24 hours. After the reaction is completed, the solvent dimethylformamide is distilled off and concentrated, and the residue is poured into water to precipitate polyurethane. This was dried under reduced pressure over phosphorus pentoxide to obtain a light brown polyurethane. This material had a high moisture content, showing a moisture content of 23%. PTMG1336/PEG1540 as alkylene diol, or
Polyurethane was synthesized using the PTMG2117/PEG2000 combination in a similar manner. The moisture content is
PU [PTMG1336/PEG1540, MDI, C-(Ser) 2 ]
42%, PU [PTMG2117/PEG2000, MDI,
C-(Ser) 2 ], it was 41%. In addition, these polyurethanes are dissolved in dimethylformamide,
The viscosity at 30°C was measured to determine [η], and the molecular weight was determined by applying the relationship between [η] and molecular weight reported for polymethyl methacrylate under these conditions. PEG1000,
MDI, C-(Ser) 2 ], [η] = 0.29, molecular weight 20
10,000, PU [PTMG1336/PEG1540, MDI, C-
(Ser) 2 ], [η] = 0.32, molecular weight 250,000, PU
[PTMG2117/PEG2000, MDI, C-(Ser) 2 ] had [η]=0.34 and a molecular weight of 290,000. PU [PTMG1100/PEG1000, MDI, C-
Figure 2 shows the IR spectrum of (Ser) 2 ] obtained by the KBr method. In this IR spectrum, 1520cm -1
The absorptions observed at (D in the figure) and 1660 cm -1 (B in the figure) are based on the amide group of the C-(Ser) 2 component. The absorption observed at 1700 cm -1 (A in the figure) is based on urethane bonds that occur as polyurethane is produced. The absorption observed at 1590 cm -1 (C in the figure) is based on the phenyl group of MDI. Based on these facts, the polyurethane obtained in the above reaction is considered to have the following structure. The production of segmented polyurethanes according to the invention is not limited to the above-mentioned cases, but also includes other cases. For example, as an amino acid having a hydroxyl group as a component of dipeptide diol used in the production of polyurethane, not only serine mentioned above but also threonine and tyrosine can be used. These α-amino acids exist in D-form and L-form, and either of them may be used. It is also possible to use a mixture or racemate of both. It is also possible to use a mixture of two or more different α-amino acids. In all these cases, both linear and cyclic dipeptides can be synthesized and used as raw materials for polyurethane. In the case of linear dipeptides, the amino and carboxyl groups must be protected. In addition to carbobenzyloxy group, as a protecting group for amino group,
A t-butyloxycarbonyl group or a formyl group can be used. Furthermore, as a protecting group for a carboxyl group, benzyl ester or amide can be used in addition to methyl ester. When PTMG and PEG are used in combination according to the method of the present invention, the moisture content of the resulting polyurethane is higher than when PTMG is used alone, and its utility as a dialysis membrane is increased. In addition to the above-mentioned MDI, examples of diisocyanates that can be used in producing polyurethane include aromatic diisocyanates such as hexamethylene diisocyanate, toluene diisocyanate, phenylene diisocyanate, and xylylene diisocyanate; Also, methylenebis(4-isocyanatocyclohexane), 1-carbomethoxy-1,6
- Diisocyanates Mention may be made of aliphatic diisocyanates such as hexane. () Method for forming a polyurethane film containing linear or cyclic dipeptide diol: To obtain a film from the polyurethane obtained as explained in () and () above, a conventional film forming method is followed. It can be done with The method is illustrated below. Example 3 Method for forming a polyurethane film under irradiation with an infrared lamp: Dissolve 0.05 g of polyurethane in 2 ml of dimethylformamide and stir overnight to form a homogeneous solution. This was cast onto a clean horizontal glass plate, a 250W infrared drying lamp was installed 30cm above the glass plate, and a transparent dust-proof case was placed to remove the evaporated dimethylformamide. The lamp was turned on for 5 hours while blowing air into the transparent case. The obtained polyurethane film easily peels off from the glass plate when immersed in distilled water. This was dried over phosphorus pentoxide for 2 days. The obtained polyurethane film is a transparent homogeneous film,
The film thickness was approximately 20 μm. The ATR-IR spectrum of this film was measured, and there was no difference between the two sides of the film.
In addition, to investigate the cross-sectional structure of this film, the film was ruptured in liquid nitrogen (-195°C) and examined using a scanning electron microscope. As a result, a large number of micropores were observed on the air-side surface of the film during film formation, which is thought to be caused by rapid evaporation of dimethylformamide due to irradiation with an infrared lamp. Example 4 Method for forming a polyurethane film at room temperature and atmospheric pressure: Dissolve 0.05 g of polyurethane in 2 ml of dimethylformamide and stir overnight to form a homogeneous solution. This was poured onto a clean horizontal glass plate, and approximately 25
The sample was left standing at room temperature (°C) under atmospheric pressure for 2 days to gradually scatter dimethylformamide, and then vacuum-dried for 3 days. The obtained polyurethane film was easily peeled off from the glass plate when immersed in distilled water. This was vacuum dried over phosphorous pentoxide for an additional 2 days. The obtained film was a transparent homogeneous film similar to the film obtained by irradiation with an infrared lamp, and the film thickness was about 20 μm. The ATR-IR spectrum of this film was measured, but there was no difference between the two sides of the film. In addition, in order to investigate the cross-sectional structure of this film, the film was ruptured with liquid nitrogen and examined using a scanning electron microscope. I couldn't help it. As the film forming method, methods other than those exemplified above can be used. When dimethylformamide is used as a solvent, a suitable temperature range is from room temperature to about 100°C. The pressure can be adjusted in the range of 1 atm to 0 mmHg. In addition to dimethylformamide, hexamethylphosphoamide, dimethylsulfoxide, and the like can be used as the film-forming solvent. Next, the biofunctionality of the polyurethane film obtained by the method of the present invention will be explained. () Urine toxicity-related substance permeability test: A membrane containing amino acid components such as the one obtained by the method of the present invention can be expected to selectively interact with solutes. , permeability was measured using a solute of uric acid. The samples used in this test are as follows. Sample (1) PU (PTMG1100/PEG1000, MDI, Z
-Ser-Ser-OMe) Sample (2) PU (PTMG1336/PEG1540, MDI, Z
-Ser-Ser-OMe) Sample (3) PU (PTMG2117/PEG2000, MDI, Z
-Ser-Ser-OMe) Sample (4) PU [PTMG1100/PEG1000, MDI, C
-(Ser) 2 ] Sample (5) PU [PTMG1336/PEG1540, MDI, C
-(Ser) 2 ] Sample (6) PU [PTMG2117/PEG2000, MDI, C
−(Ser) 2 ] Sample (7) Cellulose acetate The above samples (1) to (7) were formed into a dimethylformamide solution and formed into films by an infrared lamp irradiation method. Sample (7), cellulose acetate, is conventionally used as a dialysis membrane material for artificial kidneys, and is included for comparison. The test was conducted as follows. sample membrane
It is sandwiched between two sheets of silicone rubber with a circular hole of 0.785 cm 2 and immobilized with two dialysis cells made of methacrylic resin from both sides. (In order to improve the adhesion between the silicone rubber and the sample membrane, silicone grease was used on the parts other than the holes.) Pour 100ml of a solution of known concentration into one side of the dialysis cell and distilled water into the other side, and stir with a stirrer. The changes over time in the concentration of solutes that permeated through the tube were investigated. Furthermore, in this test, the dialysis cell was placed in a constant temperature bath at 25°C. The time-dependent change in the concentration of solutes passing through the solution 1 on the distilled water side changes over time.
ml was taken and the concentration was determined. Then, by plotting lnC''/C''- 2Ct and time t based on the theoretical permeation formula, the permeability coefficient P for each membrane was determined from the slope thereof. lnC″/C″−2C t = 2PA/δVt P: Permeability coefficient (cm 2 /min) A: Permeation membrane area (cm 2 ) δ: Film thickness (cm) V: Volume of permeation cell (cm 3 ) C″ : Initial concentration on the feed liquid side (mole/cm 3 ) C t : Concentration of the solute that permeated after t time (mole/cm 3 ) Film thickness was measured using a simple film thickness meter. The measurement of the concentration of each solute is shown below. As for NaCl, in the determination of Cl - by the Mohr method,
The amount was determined using potassium chromate as an indicator.
When 0.01N silver nitrate solution is added dropwise, AgCl
A white precipitate of Ag 2 CrO 4 forms after the end point. Urea was quantified using paradimethylaminobenzaldehyde, which was derived from Schiff's base as shown below. 0.5 ml of PDAB·H + solution was added to 1 ml of the sample, and after being left for 10 minutes, the absorbance at 440 nm was measured using UV light. On the other hand, a calibration curve was created using a urea standard solution of known concentration. This calibration curve was determined by the least squares method. Therefore, the concentration of urea can be determined from the absorbance. In addition, PDAB・H + solution is prepared by dissolving 5g of PDAB in special grade ethanol and adding 100%
ml and take about 50ml into a volumetric flask (100ml).
Gently add 5 ml of concentrated sulfuric acid, then add the PDAB solution.
PDAB·H + solution was prepared as 100 ml. A calibration curve was created for creatinine and uric acid, and the maximum extinction coefficient max was determined from the slope of the curve.
Then, the solute concentration of the sample was determined using this max. Next, since uric acid is poorly soluble in water,
A borate buffer with a pH of 9.18 was used. The measurement results are shown in the table below.
【表】
透過係数の値は約10%の誤差を含んでいる。こ
の表からPTMG/PEGの分子量が大きくなると
含水率が大きくなり透過係数も大きくなる事がわ
かる。また溶質の分子量がNaCl、尿素、クレア
チニン、尿酸と大きくなるにつれて、透過係数が
小さくなることもわかる。セルロース(試料7)
では、含水率が低いため溶質はほとんど透過しな
い。
本発明方法によつて製造された膜は上述のよう
な特異な物性を表わし、かつ抗血栓性も良好であ
ることが確認された。従つて得られた膜は人工腎
臓の透析材として優れた効果が期待される。
以上説明したところは本発明の理解を助けるた
めの代表的例示に係わるものであり、本発明はこ
れら例示に制限されることなく、発明の要旨内で
その他の変更例をとることができる。[Table] Transmission coefficient values include an error of approximately 10%. It can be seen from this table that as the molecular weight of PTMG/PEG increases, the water content increases and the permeability coefficient also increases. It can also be seen that as the molecular weight of the solute increases (NaCl, urea, creatinine, uric acid), the permeability coefficient decreases. Cellulose (sample 7)
Since the water content is low, solutes hardly pass through. It was confirmed that the membrane produced by the method of the present invention exhibits the above-mentioned unique physical properties and also has good antithrombotic properties. Therefore, the obtained membrane is expected to have excellent effects as a dialysis material for artificial kidneys. What has been described above is related to typical examples to help the understanding of the present invention, and the present invention is not limited to these examples, and other modifications can be made within the gist of the invention.
図1は本文中、例1によつて得られたPU
(PTMG2117/PEG2000、MDI,Z−Ser−Ser
−OMe)のIRスペクトル図、図2は本文中、例
2によつて得られた〔PTMG1100/PEG1000、
MDI,C−(Ser)2〕のIRスペクトル図を示す。
図1及び2において、縦軸は透過率(%)、横
軸は波数(cm-1)である。
Figure 1 shows the PU obtained in Example 1 in the main text.
(PTMG2117/PEG2000, MDI, Z-Ser-Ser
-OMe), Figure 2 is shown in the text, obtained by Example 2 [PTMG1100/PEG1000,
MDI, C-(Ser) 2 ] is shown. In FIGS. 1 and 2, the vertical axis is transmittance (%) and the horizontal axis is wave number (cm -1 ).
Claims (1)
は環状2量体とポリテトラメチレングリコール及
びポリエチレングリコールを共存させてジイソシ
アナートと重付加反応させ、得られたポリウレタ
ンを成膜することを特徴とする生体機能性膜の製
造法。1. A linear dimer or a cyclic dimer of an α-amino acid having a hydroxyl group is allowed to coexist with polytetramethylene glycol and polyethylene glycol, and a polyaddition reaction is performed with a diisocyanate, and the resulting polyurethane is formed into a film. Characteristic method for producing biofunctional membranes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58186620A JPS6077767A (en) | 1983-10-05 | 1983-10-05 | Production of living body function membrane |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58186620A JPS6077767A (en) | 1983-10-05 | 1983-10-05 | Production of living body function membrane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6077767A JPS6077767A (en) | 1985-05-02 |
| JPH0261262B2 true JPH0261262B2 (en) | 1990-12-19 |
Family
ID=16191763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58186620A Granted JPS6077767A (en) | 1983-10-05 | 1983-10-05 | Production of living body function membrane |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6077767A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201809049A (en) * | 2016-03-31 | 2018-03-16 | 盧伯利索先進材料有限公司 | Biodegradable and/or bioabsorbable thermoplastic polyurethanes |
| CN120484327B (en) * | 2025-07-10 | 2025-09-16 | 中国科学院长春应用化学研究所 | Polyurethane sponge and preparation method and application thereof |
-
1983
- 1983-10-05 JP JP58186620A patent/JPS6077767A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6077767A (en) | 1985-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5777060A (en) | Silicon-containing biocompatible membranes | |
| US6784274B2 (en) | Hydrophilic, swellable coatings for biosensors | |
| US4623347A (en) | Antithrombogenic elastomer products | |
| US4743629A (en) | Crosslinked polyetherurethane membranes useful in blood electrolyte sensors | |
| Grainger et al. | Poly (dimethylsiloxane)‐poly (ethyleneoxide)‐heparin block copolymers. I. Synthesis and characterization | |
| JPS588700B2 (en) | Method for producing antithrombotic high modulus polyurethane compound | |
| CN115417963B (en) | Biocompatible polycarbonate polyurethane, preparation method and application | |
| JPS6252602B2 (en) | ||
| Liu et al. | Preparation and characterisation of zwitterionic sulfobetaine containing siloxane-based biostable polyurethanes | |
| CN108530606B (en) | A kind of pH sensitive medical polyurethane urea material and preparation method thereof | |
| JPH0261262B2 (en) | ||
| CN117946367A (en) | A method for preparing a waterborne polyurethane leather coating containing natural antibacterial factors | |
| JPS62102815A (en) | Gas permselective membrane | |
| Su et al. | Honeycomb-like polymeric films from dendritic polymers presenting reactive pendent moieties | |
| Petrini et al. | Linear poly (ethylene oxide)-based polyurethane hydrogels: polyurethane-ureas and polyurethane-amides | |
| WO1998013685A1 (en) | Silicon-containing biocompatible membranes | |
| WO2021184843A1 (en) | Triblock copolymer for implantable biosensor, application thereof, and preparation method therefor | |
| WO2020220261A1 (en) | Biosensors coated with co-polymers and their uses thereof | |
| JPS5858123B2 (en) | gas separation membrane | |
| Huang et al. | Surface composition and protein adsorption of polyurethane membrane | |
| KR100424138B1 (en) | Temperature sensitive water vapour permeable material | |
| Tan et al. | Synthesis and properties of novel segmented polyurethanes containing alkyl phosphatidylcholine side groups | |
| JPS646220B2 (en) | ||
| JPH0239263B2 (en) | ||
| JPS61430A (en) | Selective gas permeable membrane |